Cardiac monitors are devices that
represent the heart’s electrical activity in the form of pressure
waveforms. They monitor the continuous and intermittent heart activity,
usually through electrocardiography. Cardiac rhythm management devices
are used when the heart does not function efficiently. They are placed
inside the cardiac walls for smooth and proper functioning of the heart.
The global cardiac monitoring and cardiac rhythm management devices
market is driven by increasing incidence of cardiovascular diseases at
an early age, rising obese population, increase in geriatric population,
and technological advancements in treatment options. However, factors
such as high cost incurred for the diagnosis and treatment of
cardiovascular diseases and fewer reimbursement policies in countries in
Asia Pacific are likely to restrain the global cardiac monitoring and
rhythm management devices market.
The global cardiac monitoring and rhythm
management devices market can be segmented based on product, end-user,
and geography. In terms of product, the cardiac monitoring and cardiac
rhythm market can be classified into cardiac monitoring devices and
cardiac rhythm monitoring devices. The cardiac monitoring devices
segment can be further divided into ECG devices, implantable loop
recorders, cardiac output monitoring (COM) devices, event monitor,
mobile cardiac telemetry monitoring (MCT/MCOT), and smart wearable ECG
monitors. The ECG devices sub-segment can be further classified based on
product and lead. In terms of product, the ECG devices sub-segment can
be categorized into resting ECG systems, stress ECG systems, and Holter
monitors. Based on lead, the ECG devices sub-segment can be divided into
single-lead ECG lead wires, ECG lead wires, and other ECG lead wires.
The cardiac output monitoring (COM) devices sub-segment can be further
categorized into minimally invasive COM devices and non-invasive COM
devices. The event monitoring devices sub-segment can be classified
based on product and technology. In terms of product, the event
monitoring devices sub-segment can be split into pre-symptom (memory
loop) and post-symptom event monitor. Based on technology, the event
monitoring devices sub-segment can be further divided into autodetect
monitor and manual event monitor.
The cardiac rhythm management devices
segment can be further classified into defibrillators and pacemakers.
The defibrillators sub-segment can be further categorized into
implantable cardioverter defibrillators and external defibrillators.
Implantable cardioverter defibrillators can be further divided into
transvenous implantable cardioverter defibrillators and subcutaneous
implantable cardioverter defibrillators. The transvenous implantable
cardioverter defibrillators can be further classified into biventricular
ICDS/cardiac resynchronization therapy defibrillators, dual-chamber
ICDS, and single-chamber ICDS. External defibrillators can be further
split into automated external defibrillators, manual external
defibrillators, and wearable cardioverter defibrillators. Automated
external defibrillators can be further split into fully automated
external defibrillator and semi-automated external defibrillators. The
pacemakers sub-segment can be further divided based on implantability
and type. In terms of implantability, the pacemakers sub-segment can be
further classified into implantable pacemakers and external pacemakers.
Based on type, the pacemakers sub-segment can be further split into
dual-chamber pacemakers and single-chamber pacemakers. In terms of
end-user, the cardiac monitoring and cardiac rhythm management devices
market can be segmented into hospitals, homecare, and ambulatory care
settings.
Based on geography, the cardiac
monitoring and cardiac rhythm management devices market can be divided
into North America, Europe, Asia Pacific, Latin America, and Middle East
& Africa. North America and Europe are expected to dominate the
global cardiac monitoring and cardiac rhythm management devices market
due to rise in awareness regarding use of diseases and available
treatment options. Asia Pacific is anticipated to be a region with
potential of the global cardiac monitoring and cardiac rhythm management
devices market due to increasing incidence of cardiovascular diseases,
increasing awareness among the population about regular checkups,
availability of a number of treatment options, and availability of
skilled health care professionals. Latin America and Middle East &
Africa are emerging regions of the market, with a large potential.
The prominent players in cardiac
monitoring and cardiac rhythm management devices market are Medtronic
plc, Abbott Laboratories, Boston Scientific Corporation, GE Healthcare,
and Philips Healthcare, Biotronik, Cardiac Science, Livanova, Hill-Rom
Holdings, Schiller AG, Biotelemetry, and Applied Cardiac System, among
others.
The report offers a comprehensive
evaluation of the market. It does so via in-depth qualitative insights,
historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven
research methodologies and assumptions. By doing so, the research report
serves as a repository of analysis and information for every facet of
the market, including but not limited to: Regional markets, technology,
types, and applications.
No comments:
Post a Comment